AMRX

Amneal Pharmaceuticals, Inc. Class A Common Stock
Data: 2026-09-11
Analyzing positioning… Options positioning — based on yesterday's biggest open-interest changes See the chart Institutional flows
Track record
signal day → next-day price move
Quick Stats
Sep 11, 2026

51.6

AI Score

HOLD

0.65

Volume Ratio

Oct 29, 2026

Next Earnings

13

+ve Days (30d)

17

-ve Days (30d)

AMRX Price vs Max Options Open Interest

How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.

AMRX Max Change In Options Open Interest

How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.

AMRX Options - Sort by Max open Interest (near term)

12th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

AMRX Daily Out of Money Options - Sort by Max open Interest (near term)

12th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

AMRX Daily In the Money Options - Sort by Max open Interest (near term)

12th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

AMRX Most Active Options by Volume(near term)

12th September 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track
AMRX Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select an indicator above — it will be added as a pane under the price chart with aligned dates.

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

AMRX Stock Summary

Last updated Sep 11, 2026

AMRX is currently trading at $17.01, positioned above its 200-day moving average of $14.48, indicating a long-term uptrend. The stock has a 52-week range of $9.49 to $19.26.

Technical Analysis: The 50-day moving average stands at $17.75, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 42.023, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.0, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates AMRX at 51.6/100 with a HOLD recommendation.

AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock) Indicators

Last updated Sep 11, 2026

Indicator Value
RSI(14) 42.023
CMF (20) -0.0
ROC (10) -5.552
ADX (14) 18.951
Indicator Value
MACD (12,26,9) -0.177
AROONOSC (14) -42.857
WILLAMS %R (14) -82.39
MFI (14) 35.409

AMRX Candlestick Patterns

Validated patterns fired in the last 10 sessions. Hit rate = how often price moved in the signal's direction within 5 trading days (backtest: 2.7M signals, 3,500 liquid stocks, Feb 2025–Sep 2026). Baseline: a random stock closes higher 5 days later 53% of the time. Click a row to see the candle on the chart.

Date Pattern Signal 5-Day Hit Rate Edge vs Baseline Sample
Aug 31 On-Neck Bearish 49.1% +2.1 pts 3813

These are statistical tilts, not standalone trade setups. Only patterns with a measured edge are shown — roughly 50 of 60 textbook patterns showed no edge and are hidden.

Amneal Pharmaceuticals, Inc. Class A Common Stock is above the 200 Day SMA but below the 50 Day SMA — long-term uptrend intact but under near-term pressure (Mixed).

AMRX Moving Averages Analysis

Amneal Pharmaceuticals, Inc. Class A Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Sep 11, 2026

AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock) Simple Moving Averages

Moving Averages are last updated Sep 11, 2026

Days MA
10 17.42
20 17.73
30 17.83
50 17.75
100 15.87
200 14.48

AMRX Fundamental Analysis

P/E (Forward) 6.2972
P/E (Trailing) 35.8936
Market Cap ($) 5.9 billion
Earnings/Share ($) 0.47
Net Profit Margin (%) 0.0505
Dividend/Share ($) --
EPS Estimate Current Year ($) 1.008
EPS Estimate Next Year ($) 1.161
WallStreet Target Price ($) 21.00
Most Recent Quarter

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.